Study to Analyze the Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06191055 | Completed DMC

• 1 other identifier: UCAMCFE-00030
• Study Type: interventional
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

Randomized, controlled, double-blind, single-center, controlled clinical trial with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) to measure the efficacy of 28-day consumption of a sustained-release beta alanine on the physiological efficacy of physical performance in recreational cyclists.

Conditions

Beta Alanine Supplementation

Keywords

Chronic effect; Beta Alanine

Outcome Measures

Primary Outcomes (2)

• Power

  Physical performance is measured by direct variables evaluated by the power roller (average power, maximum power, etc.).

  It will be measured on two different occasions. The first day and twenty-eight days later.

• Distance covered

  Physical performance is measured by direct variables evaluated by the power roller.

  It will be measured on two different occasions. The first day and twenty-eight days later.

Secondary Outcomes (9)

• Fatigue

  Change of baseline rate of perceived exertion at twenty-eight days

• Paresthesia test

  It will be measured on two different occasions. on day 1 (before consumption) and twenty-eight days after (after consumption).

• Microcapillary blood

  It will be measured on two different occasions. Day one and twenty-eight days later.

• Lactate

  It will be measured on two different occasions. Day one and twenty-eight days later.

• Heart Rate

  It will be measured on two different occasions. Day one and twenty-eight days later.

Study Arms (3)

Beta Alanine high dose

EXPERIMENTAL

Consumption for 28 days.

Dietary Supplement: Beta Alanine high dose

Beta Alanine low dose

EXPERIMENTAL

Consumption for 28 days.

Dietary Supplement: Beta Alanine low dose

Control group

PLACEBO COMPARATOR

Consumption for 28 days.

Other: Control group

Interventions

Beta Alanine high dose DIETARY_SUPPLEMENT

4 intakes of 5 g of beta alanine every 3 hour.

Beta Alanine high dose

Beta Alanine low dose DIETARY_SUPPLEMENT

4 intakes of 2.5 g of beta alanine every 3 hour.

Beta Alanine low dose

Control group OTHER

4 intakes of 2.5 g of wheat semolina every 3 hour.

Control group

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: male
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Male cyclists with more than two years of cycling experience.
• Perform tests without fatigue.
• Road bike training at least twice a week.

You may not qualify if:

• Participants with chronic illness.
• Have a long-term injury that prevents you from training in the previous month.
• Inability to understand informed consent.
• Have consumed beta alanine in the three years prior to the start of the study.
• Consumption of other supplements that may alter performance.

Sponsors & Collaborators

• Universidad Católica San Antonio de Murcia: lead

Study Sites (1)

Catholic University of Murcia

Murcia, 30107, Spain

Location

MeSH Terms

Interventions

beta-Alanine; Control Groups

Intervention Hierarchy (Ancestors)

Alanine; Amino Acids; Amino Acids, Peptides, and Proteins; Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 2, 2023
• First Posted: January 5, 2024
• Study Start: December 4, 2023
• Primary Completion: February 5, 2024
• Study Completion: March 11, 2024
• Last Updated: May 17, 2024

Record last verified: 2023-11

Locations

ES (1)